In secondary sarcopenia models, ST revealed early atrophy markers such as Xirp1, Cryab, and polyamine-pathway enzymes selectively enriched in glycolytic regions, suggesting spatially restricted intervention points. This evidence concerns the gene CRYAB and sarcopenia.